Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Engineered tissue constructs offer alternatives to organ transplantation for liver failure.
• Poly(ethylene glycol) (PEG)-based hydrogels are suitable for engineered liver tissue construction.
• Previous PEG-diacrylate (PEGDA) hydrogels are non-degradable, limiting long-term cell function.

Purpose of the Study:

• To develop and evaluate a novel hydrogel system for engineered liver tissue.
• To create a stable yet degradable hydrogel for hepatocyte culture and implantation.
• To assess the in vitro and in vivo functionality of engineered liver tissue within the new hydrogel.

Main Methods:

• Synthesized poly(ethylene glycol)-diacrylamide (PEGDAAm) hydrogels with matrix-metalloproteinase (MMP)-sensitive linkers.
• Encapsulated primary hepatocytes and optimized culture conditions (polymerization, cell density, multicellular composition).
• Implanted PEGDAAm-based engineered liver tissues into nude mice and assessed survival and function for over 3 weeks.

Main Results:

• PEGDAAm hydrogels demonstrated resistance to non-specific hydrolysis while allowing MMP-mediated degradation.
• Optimized hydrogel conditions enhanced the magnitude and duration of hepatic function in vitro.
• Implanted PEGDAAm liver tissues remained viable and functional for over three weeks in mice.

Conclusions:

• MMP-sensitive PEGDAAm hydrogels provide a stable and functional microenvironment for engineered liver tissues.
• This hydrogel system supports long-term hepatic function both in vitro and after ectopic implantation.
• PEGDAAm-based hydrogels represent a promising material for tissue engineering and regenerative medicine applications.